Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 28,838 | 12,448 | 0 | 0 | 0 |
| Cost of Goods | 4,262 | 1,712 | N/A | N/A | N/A |
| Gross Profit | 24,576 | 10,737 | N/A | N/A | N/A |
| Operating Expenses | 13,879 | 12,436 | 15,343 | 8,183 | 6,336 |
| Operating Income | 10,959 | -988 | -14,843 | -8,183 | -6,336 |
| Other Income | 450 | 343 | 344 | 344 | 371 |
| Pre-tax Income | 11,410 | -645 | -14,500 | -7,839 | -5,965 |
| Income Tax | 450 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 10,960 | -645 | -14,500 | -7,839 | -5,965 |
| Net Income | $10,960 | $-645 | $-14,500 | $-7,839 | $-5,965 |
| EPS Basic Total Ops | 0.11 | -0.01 | -0.13 | -0.08 | -0.06 |
| EPS Basic Continuous Ops | 0.11 | -0.01 | -0.14 | -0.08 | -0.06 |
| EPS Diluted Total Ops | 0.10 | -0.01 | -0.13 | -0.08 | -0.06 |
| EPS Diluted Continuous Ops | 0.10 | -0.01 | -0.14 | -0.08 | -0.06 |
| EBITDA(a) | $11,026 | $-914 | $-15,331 | $-8,173 | $-6,328 |